| Basics |
|
Kodiak Sciences Inc
|
| IPO Date: |
October 1, 2018 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.29B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.04 | 3.78%
|
| Avg Daily Range (30 D): |
$0.81 | 4.08%
|
| Avg Daily Range (90 D): |
$0.74 | 5.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.44M |
| Avg Daily Volume (30 D): |
.66M |
| Avg Daily Volume (90 D): |
.73M |
| Trade Size |
| Avg Trade Size (Sh.): |
87 |
| Avg Trade Size (Sh.) (30 D): |
72 |
| Avg Trade Size (Sh.) (90 D): |
80 |
| Institutional Trades |
| Total Inst.Trades: |
1,323 |
| Avg Inst. Trade: |
$2.26M |
| Avg Inst. Trade (30 D): |
$1.17M |
| Avg Inst. Trade (90 D): |
$1.18M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.69M |
| Avg Closing Trade (30 D): |
$1.29M |
| Avg Closing Trade (90 D): |
$1.3M |
| Avg Closing Volume: |
61.31K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-4.12
|
$-1.16
|
|
|
Diluted EPS
|
$-4.12
|
$-1.16
|
|
|
Revenue
|
$ M
|
$ M
|
$
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -217.34M
|
$ -61.46M
|
$ -54.31M
|
|
Operating Income / Loss
|
$ -223.11M
|
$ -62.35M
|
$
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -125.83M
|
$
|
$
|
|
PE Ratio
|
|
|
|
|
|
|